Rossana Vasconcelos | Health and Medicine Advances | Editorial Board Member

Published on by New Scientists

Dr. Rossana Vasconcelos | Health and Medicine Advances | Editorial Board Member

Teacher | University of Santo Amaro | Brazil

Dr. Rossana Vasconcelos is a Brazilian dermatologist whose scholarly contributions span clinical dermatology, cosmetic dermatology, and aesthetic science. With 55 citations, 15 indexed publications, and an h-index of 3 in Scopus, her research presence reflects sustained engagement in advancing dermatological knowledge, particularly within the fields of skin health, cosmetic procedures, and patient-centered aesthetic care. Her academic work focuses on integrating evidence-based dermatological practice with emerging cosmetic technologies. Dr. Rossana Vasconcelos has contributed to peer-reviewed journal publications highlighting innovative approaches in skin treatments, dermatologic surgery, and cosmetic applications designed to enhance patient safety and therapeutic outcomes. Her conference outputs further expand her role in disseminating insights on aesthetic dermatology, emphasizing practical innovations and contemporary trends in minimally invasive procedures. In addition to scholarly publications, she has fostered research and mentorship within dermatology, promoting clinical inquiry into skin physiology, anti-aging strategies, cosmeceutical effectiveness, and procedural dermatology. Her research interests include dermato-cosmetic techniques, skin rejuvenation methodologies, pigmentation disorders, and interdisciplinary approaches linking dermatology with aesthetics, well-being, and lifestyle science. Dr. Rossana Vasconcelos has been active in dermatology communities through contributions aligned with the Brazilian Society of Dermatology (SBD) and the Brazilian Society of Dental Surgery (SBCD), supporting scientific engagement and knowledge dissemination. Her research-related recognitions reflect her commitment to combining clinical expertise with continuous academic development. She participates in peer-review activities aligned with dermatology journals and maintains a growing impact through collaborative clinical projects and aesthetic dermatology research initiatives. Her scholarly trajectory is shaped by a balance of scientific curiosity, clinical excellence, and innovative exploration of cosmetic dermatology, resulting in meaningful contributions to the dermatological research landscape in Brazil. Driven by dedication, creativity, and a deep engagement with human well-being, Dr. Rossana Vasconcelos continues to advance research that bridges science, aesthetics, and patient-centered dermatologic care.

Profiles: Scopus | ResearchGate

Featured Publications

1. Amiri, M., Ajasllari, G., Llane, A., & Fabi, S. G. (2025, October). Enhancing methodological rigor in MFU-V meta-analyses: A commentary on evidence synthesis and interpretation. Aesthetic Surgery Journal.

2. Crocco, E., Vasconcelos, R. C. F., Andrade, C. S., & Coutinho, A. L. (2025, August). Treatment of acne vulgaris with a topical application of retinaldehyde, glycolic acid, and Silybum marianum fruit extract: A pilot study. Cureus.

3. Oliveira, G., Cordeiro, A. A. R., Portela, L. C., Crocco, E., & Vasconcelos, R. C. F. (2025, July). Impact of unlawful aesthetic practices in Brazil: A multicenter survey on complications and the need for regulatory reform. Dermatologic Surgery.

4. Di Sessa, D., Pecora, C. de S., Vasconcelos, R. C. F., & Moreira, G. L. (2025, May). Single session of calcium hydroxylapatite, incobotulinumtoxin A, and hyaluronic acid for gluteal aesthetic improvement. Journal of Cosmetic Dermatology.

5. Vasconcelos, R., Arruda, P., Heredia-Combariza, N., & Almeida, A. T. de. (2025, May). Recommendations for the use of Cohesive Polydensified Matrix (CPM) filler technology for facial rejuvenation by the Latin American Expert Group (LAEG). Journal of Plastic, Reconstructive & Aesthetic Surgery.

Akash Mourya | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Mr. Akash Mourya | Health and Medicine Advances | Best Researcher Award

PhD Scholar | National Institutes of Pharmaceutical Education and Research | India

Mr. Akash Mourya is a promising young pharmacologist specializing in pharmacology and toxicology, with a strong research focus on liver pathophysiology, hepatoprotective drug discovery, and molecular mechanisms underlying hepatic and pulmonary disorders. His ongoing Ph.D. work at NIPER Mohali builds on extensive preclinical and translational research conducted at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where he has developed expertise in animal models of liver diseases, hemodynamic studies, and hepatic cell culture systems. His research contributions have advanced understanding of non-alcoholic and alcoholic fatty liver diseases, hepatopulmonary and porto-pulmonary hypertension, and liver regeneration mechanisms. He has co-authored seven peer-reviewed publications in high-impact journals, including Journal of Hepatology, JHEP Reports, American Journal of Physiology–Gastrointestinal and Liver Physiology, npj Gut and Liver, ACS Omega, and Life Sciences. His work has collectively received 31 citations, 7 Documents, with an h-index of 3, reflecting growing recognition within the biomedical research community. In addition to journal articles, Mr. Akash Mourya has contributed two book chapters published by Springer Nature (2024) and Academic Press (2025), covering topics such as oxidative stress and pharmacological interventions in liver disease, and PPARγ signaling in diabetes. His research abstracts have been presented at prestigious international conferences, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). His work integrates pharmacological innovation, molecular biology, and experimental therapeutics, with emphasis on Ayurvedic formulations, CB2 receptor agonists, and novel siRNA nanoparticle delivery systems. Mr. Akash Mourya’s ongoing efforts contribute to translational R&D for liver protection and regeneration, aligning with India’s growing emphasis on integrative pharmacology and precision medicine.

Profiles: Scopus | Google Scholar | ResearchGate | PubMed 

Featured Publications

1. Baweja, S., Kumari, A., Negi, P., Tomar, A., Tripathi, D. M., Mourya, A. K., Rastogi, A., Subudhi, P. D., Thangariyal, S., Kumar, G., Kumar, J., Sood, A., Vashistha, C., Bihari, C., Maiwall, R., & Sarin, S. K. (2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Journal of Hepatology, 79(1), 167–180.

2. Juneja, P., Rahman, S. N. R., Jakhar, D., Mourya, A. K., Tripathi, D. M., Kaur, I., Tiwari, V., & others. (2023). Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis. JHEP Reports, 5(10), 100816.

3. Biswas, S., Yadav, N., Juneja, P., Mourya, A. K., Kaur, S., Tripathi, D. M., & Chauhan, V. S. (2022). Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis. ACS Omega, 7(41), 36811–36824.

4. Kaur, I., Juneja, P., Tiwari, R., Vasudevan, A., Mourya, A. K., Trauner, M., Sarin, S. K., & Tripathi, D. M. (2024). Secondary bile acids in portal blood contribute to liver regeneration in a rat model of partial hepatectomy. American Journal of Physiology – Gastrointestinal and Liver Physiology, 327(4), G645–G658.

5. Tripathi, D. M., Singh, P., Mourya, A. K., & Kaur, S. (2024). Oxidative medicine and novel pharmacological treatment approaches in liver disease. In Adaptation under stressful environments through biological adjustments and interventions (pp. 311–334). Springer Nature.